Confirmation of gene expression-based prediction of survival in non-small cell lung cancer
about
The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cellsNew perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformaticsSystematic analysis of multi-walled carbon nanotube-induced cellular signaling and gene expression in human small airway epithelial cellsMulti-walled carbon nanotube-induced gene expression in the mouse lung: association with lung pathologyMultiwalled carbon nanotube-induced gene signatures in the mouse lung: potential predictive value for human lung cancer risk and prognosisHybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse predictionThe structure, function and evolution of proteins that bind DNA and RNAApolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trialThe expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohortsIs there clinical value to prognostic signatures in early-stage NSCLC?Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor developmentA robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinomaNovel image markers for non-small cell lung cancer classification and survival predictionTal2 expression is induced by all-trans retinoic acid in P19 cells prior to acquisition of neural fateInterleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivinCombining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based studyLung Cancer Gene Signatures and Clinical PerspectivesA novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLCNF90 in posttranscriptional gene regulation and microRNA biogenesisCombining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancerThe T-cell oncogene Tal2 Is a Target of PU.1 and upregulated during osteoclastogenesisThe NF90-NF45 complex functions as a negative regulator in the microRNA processing pathwayInterleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expressionForfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCCColorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in cultureReinventing diagnostics for personalized therapy in oncologySuppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell Proliferation in Hepatocellular CarcinomaFrom Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical ResearchHigh Energy Particle Radiation-associated Oncogenic Transformation in Normal Mice: Insight into the Connection between Activation of Oncotargets and Oncogene AddictionPeripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapyGene expression-based classification of non-small cell lung carcinomas and survival predictionMiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axisOverexpression of NF90-NF45 Represses Myogenic MicroRNA Biogenesis, Resulting in Development of Skeletal Muscle Atrophy and Centronuclear Muscle FibersHighlight report: Validation of prognostic genes in lung cancerCancer research: from prognostic genes to therapeutic targetsPrognostic value of microRNA expression in operable non-small cell lung cancer patientsCapillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnosticsIntegrated DNA Copy Number and Gene Expression Regulatory Network Analysis of Non-small Cell Lung Cancer MetastasisNovel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecyclesNanoscale hybrid systems based on carbon nanotubes for biological sensing and control.
P2860
Q23909716-7013B3A2-FE4F-4BB6-AACB-2296BD885F78Q23910479-C093DA5F-9085-46C5-B2C1-E3EB5D623D85Q23910480-28577DA4-3C00-41AA-A26A-73143AEA4604Q23917421-2601782A-8DB6-44FA-AE99-6F76E89A54F4Q23918758-AD85B472-D1E3-4A16-BA12-C4DA87C07C63Q23924046-821ECF86-4A68-4BB4-A690-DAD61A7E2AC5Q27003938-2E969857-F851-410F-A049-C08C5AA74F66Q28383260-2AFE9F67-0FCB-4EB0-81ED-7CB9FDB2AAFCQ28383695-A34F3129-0A9C-4BE9-BDC0-708BDD39B596Q28384571-D128A0EB-44D0-41E3-A9BE-F994E5FB7F05Q28384678-3457BD6C-B838-4E56-A4C7-2F715658EDC5Q28385552-59D16B93-E985-40CC-8AC8-8E3D627AFEBAQ28385611-94F3724B-3353-42B1-9E15-0FC32859049BQ28385623-CC45C2DE-4252-4E7F-9E92-9541DF8DC463Q28386284-686919CB-C25B-4C79-A25B-E6DA40490DDEQ28386520-F782CD8C-2E8A-4B4E-A71E-C07F41216DFBQ28387769-BAA57BDF-7A85-4F55-9E01-42E25F7FF36CQ28387995-8DE7535B-400F-46B9-9190-D899C5589AA1Q28388023-E76D516F-EC01-47D9-B6DE-B2F05D41343DQ28388778-F415665C-5A6E-491F-9CC7-1ECC1E51CB37Q28389140-A3489C4E-7287-415E-B3D6-E237DF0BA612Q28389364-5F0DD13C-4B8A-46E6-9C2A-829382D78CFFQ28390678-6B42A494-5C38-4DDA-A0FF-EBA2691BF3BCQ28390991-B95CB8EC-FBC7-4C89-9290-B61F96E75D7CQ28391219-F40A073E-D6CC-4173-AECB-681C6383C104Q28391395-FDA87F6B-E0B9-4745-8AB9-9E71C4961DEDQ28392330-AFD18BEB-7D25-4AD6-9100-1A498D4099C8Q28393309-6EACEB40-22F4-46C6-9996-CD784EDB6BA6Q28394701-288716D8-2AB4-4E1D-8089-3FE08451A290Q28394867-CCFF6CA2-DB9C-43FF-85B9-FE651BA4DB5DQ28395058-75BE617E-5886-499C-855E-E83D958BA001Q28395657-7055B3EF-F397-4BA4-A920-6FB543B55713Q28395692-F486E821-AD7E-476C-B941-5875B88BE086Q28396184-FCFE1A65-9690-4021-BD94-71CE162ECE01Q28396195-7BF39305-37A2-4F27-8554-19F786AF3389Q28396343-4E3AFB68-2053-43F8-B472-C5C1B40DA965Q28396457-17EC95DD-99BC-44C5-9732-FBDEF9205F6CQ28397049-EF800CFD-EAA3-46B4-9A77-6573FB9CE891Q28397941-D418A53A-2F3A-4FC2-B873-D346A9330279Q33832785-A1DF6759-9494-48EE-8EEE-323AAC8A2373
P2860
Confirmation of gene expression-based prediction of survival in non-small cell lung cancer
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Confirmation of gene expressio ...... in non-small cell lung cancer
@ast
Confirmation of gene expressio ...... in non-small cell lung cancer
@en
Confirmation of gene expressio ...... in non-small cell lung cancer
@en-gb
Confirmation of gene expressio ...... in non-small cell lung cancer
@nl
type
label
Confirmation of gene expressio ...... in non-small cell lung cancer
@ast
Confirmation of gene expressio ...... in non-small cell lung cancer
@en
Confirmation of gene expressio ...... in non-small cell lung cancer
@en-gb
Confirmation of gene expressio ...... in non-small cell lung cancer
@nl
prefLabel
Confirmation of gene expressio ...... in non-small cell lung cancer
@ast
Confirmation of gene expressio ...... in non-small cell lung cancer
@en
Confirmation of gene expressio ...... in non-small cell lung cancer
@en-gb
Confirmation of gene expressio ...... in non-small cell lung cancer
@nl
P2093
P2860
P50
P921
P3181
P1476
Confirmation of gene expressio ...... in non-small cell lung cancer
@en
P2093
Afshin Dowlati
Daniel C Flynn
David G Beer
Kursad Tosun
Nancy L Guo
Scot C Remick
Ying-Wooi Wan
Zola Msiska
P2860
P2880
P304
P3181
P356
10.1158/1078-0432.CCR-08-0095
P407
P577
2008-12-15T00:00:00Z